7 digital health 'unicorn' exits in 2020

With digital health adoption rates skyrocketing from the COVID-19 pandemic, healthcare 'unicorn' activity hit record levels in 2020, according to a recent CB Insights report.

The digital health space saw seven 'unicorn' companies, or private companies valued at more than $1 billion, exit. The exit activity, which is when the company goes public or is acquired, nearly doubled the four exits in 2019 and two exits in 2018.

Here are the seven digital health unicorns that exited in 2020 as well as their valuations:

  • GoodRx: $12.7 billion
  • Grail: $8 billion
  • Gan & Lee: $3.6 billion
  • Cure Vac: $2.8 billion
  • One Medical: $1.7 billion
  • Hims & Hers $1.6 billion
  • Butterfly: $1.5 billion

© Copyright ASC COMMUNICATIONS 2021. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Featured Whitepapers

Featured Webinars